Evidence map›Paper›PMID 28410005›Full record

ArticleAdipocyte2017

Meeting report of the 2016 bone marrow adiposity meeting.

Bram van der Eerden, André van Wijnen

Open access · goldAbstract readConference Proceedings
In one paragraph

Article in Adipocyte, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Bone Marrow Fat and Hematopoiesis.Frontiers in endocrinology · 2018
    Review
  8. Bone marrow adipocytes.Adipocyte · 2017
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Bram van der Eerdena Erasmus MC, Department of Internal Medicine , Laboratory for Calcium and Bone Metabolism , Rotterdam , the Netherlands.
André van Wijnenb Mayo Clinic, Department of Orthopedic Surgery and Biochemistry & Molecular Biology , Rochester , MN , USA.
Erasmus University Rotterdam · NLMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is considerable interest in the physiology and pathology, as well as the cellular and molecular biology, of bone marrow adipose tissue (BMAT). Because bone marrow adiposity is linked not only to systemic energy metabolism, but also to both bone marrow and musculoskeletal disorders, this biologic compartment has become of major interest to investigators from diverse disciplines. Bone marrow adiposity represents a virtual multi-tissue endocrine organ, which encompasses cells from multiple developmental lineages (e.g., mesenchymal, myeloid, lymphoid) and occupies all the non-osseous and non-cartilaginous space within long bones. A number of research groups are now focusing on bone marrow adiposity to understand a range of clinical afflictions associated with bone marrow disorders and to consider mechanisms-based strategies for future therapies.

Indexed as

AdiposityBone MarrowAdipose TissueAnimalsBone and BonesBone Marrow CellsCell DifferentiationCell LineageEnergy MetabolismHematopoiesisHumansMesenchymal Stem CellsNeoplasmsadipocyteadipositybone marrowbone marrow adipose tissuefat

Identifiers

PMID28410005
PMCPMC5736244
OpenAlexW2604435015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.